Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Luca Arcaini, Annalisa Arcari et al.|The Oncologist|2018Cited by 69
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCLMaria Chiara Tisi, Carlo Visco, Riccardo Moia et al.|Blood Advances|2023Cited by 23
Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell LymphomasMarco Lucioni, Antonio Di Sabatino, Sara Fraticelli et al.|Cancers|2023Cited by 14
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 studyCarlo Visco, Monica Balzarotti, Valentina Tabanelli et al.|The Lancet Haematology|2025Cited by 6
<i>TP53</i>, <i>CD36</i> Mutations and <i>CDKN2A</i> Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 TrialRiccardo Moia, Carlo Visco, Maria Elena Carazzolo et al.|Blood|2024Cited by 3